News Archive - Stand Up to Cancer

News

LATEST UPDATES

READ MORE

Beyond the Norm

A number of approved therapies can be used to treat pancreatic cancer, but many experts say that clinical trials offer patients greater hope.

Read More
READ MORE

Challenges to Curing Primary Brain Tumours

Despite decades of research, brain tumours remain among the deadliest of all forms of cancer. The ability of these tumours to resist almost all conventional and novel treatments relates, in part, to the unique cell-intrinsic and microenvironmental properties of neural tissues.

Read More
READ MORE

Trump’s $500 million for childhood cancer? Scientists have ideas how to spend it

Vice Chair of the SU2C Scientific Advisory Committee, Lee J. Helman, MD comments on the $500MM for pediatric cancer recommended in the State of the Union speech could bring additional researchers into the field of pediatric cancer research.

Read More
READ MORE

Stand Up to Cancer Unveils $50M Endowment Fund Goal

The endowment will be used to support SU2C’s annual operating activities and fund its life-saving cancer research.

Read More
READ MORE

Can These Researchers Catch Cancer Much Earlier Than Ever Before?

SU2C “Convergence” and “Cancer Interception” researchers Regina Barzilay, PhD and Lecia Sequist. MD, PhD discuss AI to find cancers earlier, even before abnormal cells turn into the disease.

Read More
READ MORE

Dr. Carl June Highlights Shorter CAR T Culture Times at SITC

Pancreatic Cancer Collective scientists, Dr. Carl June and Dr. David Tuveson suggest CAR T cell therapies can require as little as three days of culture time at SITC 2018.

Read More
READ MORE

New Funding Opportunity: Pancreatic Cancer Collective – Computational Approaches to Identifying High-Risk Pancreatic Cancer Populations

The Pancreatic Cancer Collective (PCC) invites applications for the Pancreatic Cancer Collective – Computational Approaches to Identifying High Risk Pancreatic Cancer Populations Grant. The Team(s) will develop tools to identify individuals in the general population who are at high risk for pancreatic cancer far earlier than they would otherwise be diagnosed, using information from existing dataset(s) (such as the OptumLabs Data Warehouse*, UK Biobank*, Danish National Patient Registry*, and/or other comparable datasets).

Read More
READ MORE

“I was the new Nobel Prize winner’s lab rat… Dr. James P. Allison won the Nobel Prize for his work with immunotherapy, which saved my life.” by SU2C-CRI Dream Team Advocate Mary Elizabeth Williams in SALON

Receiving the Nobel prize is an extraordinary lifetime achievement, but the impact of Dr. Jim Allison’s research can be life-changing for the patients who benefit, as shared in this personal account.

Read More
READ MORE

American Cancer Society Updates Colorectal Cancer Screening Guideline

The American Cancer Society (ACS) has released an updated guideline for colorectal cancer screening. Among the major guideline changes, the new recommendations say screening should begin at age 45 for people at average risk. Previously, the guideline recommended screening begin at age 50 for people at average risk. Recommendations for screening test options are also part of the guideline changes.

Please click here to learn more.

Read More
READ MORE

Nut Consumption May Aid Colon Cancer Survival

Charles S. Fuchs, MD, co-leader of the SU2C Colorectal Cancer Dream Team, is also head of a research that recently reported an intriguing finding: people with stage III colon cancer who regularly eat nuts are at significantly lower risk of cancer recurrence and mortality than those who don’t. The study followed 826 participants in a clinical trial for a median of 6.5 years after they were treated with surgery and chemotherapy. Those who regularly consumed at least two, one-ounce servings of nuts each week demonstrated a 42% improvement in disease-free survival and a 57% improvement in overall survival, according to a paper published in the Journal of Clinical Oncology. Earlier research among patients with colon cancer has indicated that patients are more likely to have poor outcomes when lifestyle factors such as obesity, high carbohydrate diet and lack of exercise increases their insulin resistance or raises blood sugar levels. “These studies support the hypothesis that behaviors that make you less insulin resistant, including eating nuts, seem to improve outcomes in colon cancer,” Fuchs said. “However, we don’t know yet what exactly about nuts is beneficial.” Nuts also might play a positive role by satisfying hunger with less intake of carbohydrates or other foods associated with poor outcomes, Fuchs noted. Dr. Fuchs is director of the Yale Cancer Center and physician-in-chief at the Smilow Cancer Hospital.

For more information, please click here.

Read More

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Thank you for your form submission. You will hear from us soon

Stand Up With Us Today

Cancer tragically connects all of us: our children, our siblings, our spouses, our friends and family. But in that connection, we can come together in triumph and Stand Up To Cancer.

Will you join us?

   Please leave this field empty
Thank you for your form submission. You will hear from us soon